OptimizeRx Corp
OptimizeRx (Nasdaq: OPRX) is a digital healthcare technology company that provides marketing and patient-support solutions to life sciences organizations, including pharmaceutical manufacturers, medical device companies and their agencies. Its platform combines artificial intelligence and machine learning with an… From the company’s description.
Over the twelve months to Jun 30, 2026, OptimizeRx Corp reported revenue of $98.65M, down 5.8% from a year earlier, and net income of $4.60M. Its operating margin was 11.1%, and operations generated $18.43M in cash. In fiscal 2025, it reported revenue of $109.43M, up 18.8% from fiscal 2024, and net income of $5.13M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What OptimizeRx Corp does
In the company’s own words
OptimizeRx (Nasdaq: OPRX) is a digital healthcare technology company that provides marketing and patient-support solutions to life sciences organizations, including pharmaceutical manufacturers, medical device companies and their agencies. Its platform combines artificial intelligence and machine learning with an omnichannel network to identify and engage healthcare professionals and patient audiences through electronic health record systems, e-prescribing platforms, programmatic advertising and other digital channels. Solutions include Dynamic Audience Activation Platform for predictive audience development, Micro-Neighborhood® Targeting for privacy-focused geographic targeting of consumer audiences, Profiler for audience insights, Pharmacy Alerts for prescription availability, and financial messaging that presents branded copay offers to prescribers. The company also executes healthcare professional and direct-to-consumer campaigns across display, connected television, social media, audio and other media. OptimizeRx was founded in 2006 and expanded into direct-to-consumer marketing through its 2023 acquisition of Medicx Health. It served more than 100 pharmaceutical manufacturers and connected over two million U.S. healthcare providers through its network; it had 133 full-time and one part-time employee at year-end 2025. Its website is www.optimizerx.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Business Services
- Headquarters
- WALTHAM, MA
- Fiscal year end
- December
- CIK
- 1448431
- SIC
- 7389
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns OptimizeRx Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · OptimizeRx Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do OptimizeRx Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of OptimizeRx Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in OptimizeRx Corp's last four quarterly filings that the numbers alone won't show?”